SEC 13F Intelligence

Innovis Asset Management LLC / BSX

Innovis Asset Management LLC’s Boston Scientific Corp Position

Does Innovis Asset Management LLC own Boston Scientific Corp (BSX)? Yes — 136.8K shares worth $7M (+2.78% of its 13F portfolio) as of Q3 2023, up from 106.0K shares the prior filed quarter.

Position Value
$7M
Q3 2023
Shares
136.8K
% of Portfolio
+2.78%
Quarters Held
4
currently held

Position History BSX

Reported value by quarter
Q4 ’22: $2MQ4 ’22Q1 ’23: $4MQ1 ’23Q2 ’23: $6MQ2 ’23Q3 ’23: $7MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023136.8K$7M+2.78%
Q2 2023106.0K$6M+2.12%
Q1 202375.7K$4M+1.54%
Q4 202252.0K$2M+1.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Innovis Asset Management LLC’s full portfolio or all institutional holders of BSX.